Dixie Elixirs inks infused-product licensing deal to expand Down Under

Warning message

The subscription service is currently unavailable. Please try again later.

One week after announcing a deal to put its products into Oregon and Arizona pot shops, the licensing arm of Denver-based Dixie Elixirs on Thursday announced its first international foray — into Australia and New Zealand.

Dixie Brands and its Australian partner, Cann Group, announced two licensing agreements Thursday night at the Marijuana Business Conference in Las Vegas.

The first deal will help launch Dixie-branded, Cann Group-formulated topicals and cosmetics infused with nonpsychoactive cannabinoid CBD in Australia and New Zealand early next year. The second will bring Dixie’s full line of THC-infused edibles, topicals and tinctures to market if and when medical marijuana programs launch in Australia and New Zealand.

“Essentially, Dixie has signed a license agreement with our company to bring all of Dixie’s product lines now, and whatever they come up with, to Australia and New Zealand,”...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.